Qinecsa COO, John Cogan, has been featured in Pharmaceutical Outsourcing’s latest issue, where he discusses why adverse event case processing is an enormous cost center and compliance issue for life sciences and outsourcing can alleviate pressure, free up internal resources, and drive down cost.
